Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease - Quiz - MDSpire

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  • By

  • Jie Su

  • Dalia A Lartey

  • Gaia Zanella

  • Lukas J A C Hawinkels

  • Gianluca Matteoli

  • Mark Löwenberg

  • Marieke C Barnhoorn

  • May 24, 2025

  • 0 min

Share

Original Source(s)

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  • by Jie Su, Dalia A Lartey, Gaia Zanella, Lukas J A C Hawinkels, Gianluca Matteoli, Mark Löwenberg, Marieke C Barnhoorn

  • May 24, 2025

Related Content

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

Factors Linked to Moderate-to-Severe Ulcerative Colitis: Insights from a Retrospective Case-Control Analysis

Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry